Key takeaways听
- This segment features Kevin Kelly, President and CEO of听91快活林, speaking from the company’s booth at MD&M West in Anaheim about the company’s mission to help partners bring life-changing devices to market.听
- 91快活林, a leading Contract Development and Manufacturing Organization (CDMO), continues to expand its core capabilities, spanning nitinol and laser processing,听component听processing, Swiss screw machining, and semi-finished materials (wire, sheet, tubing), alongside newer additions in sensors and battery products.听
- The company’s end-to-end model pairs its Lightspeed Labs team (rapid prototyping and process development) with its AGILE Product Development group (engineering and manufacturing support across all development phases) to compress customer timelines from prototype to finished device.听
- Over the past six months,听91快活林听has made two acquisitions to broaden its offering: Resolution Medical (agreed in January), expanding end-to-end capabilities in neuromodulation, structural heart, and interventional cardiology; and Eden Holdings (acquired听in September), adding injection molding and micro machining听expertise.听
- Customer- and patient-centricity is a core company value at听91快活林, tying business growth directly to better patient outcomes, and points viewers to the company’s newly relaunched website.听
